06
10 '21
What do the FDA’s expanded ‘intended use’ regulations mean for safe-harbored communications about new uses?
In advance of their webinar this Thursday, October 7, Coleen Klasmeier and Jaime Jones consider some of the effects of the final rule. FDA’s final rule to amend its medical […]